Aprogen 生物制剂公司 - 收益表 (TTM)

Aprogen 生物制剂公司
KR ˙ KOSE ˙ KR7003060001
₩647.00 ↑24.00 (3.85%)
2025-09-08
分享价格
收益表 (TTM)

Aprogen 生物制剂公司 损益表显示一段时间内收入和支出的变化。损益表数据包括销售和收入、毛利、研发、销售、一般和管理费用、经营收入、所得税费用、利息费用、营业外收入、每股收益和已发行股票。

除每股单位外,所有数字都是 1,000,000。

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
收入 55,488 53,320 51,762 53,428 54,682 56,482 61,063 61,130 62,481 65,190 65,779 77,627 81,744 87,364 85,518 73,635 68,033 67,378 68,620 68,324
改变 (%) -3.91 -2.92 3.22 2.35 3.29 8.11 0.11 2.21 4.34 0.90 18.01 5.30 6.87 -2.11 -13.90 -7.61 -0.96 1.84 -0.43
收入百分比 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
销售成本 32,000 30,515 29,644 30,178 30,584 31,607 34,476 34,629 36,121 39,380 50,375 69,414 83,425 99,337 92,915 80,342 71,660 75,224 84,850 95,095
改变 (%) -4.64 -2.86 1.80 1.35 3.34 9.08 0.45 4.31 9.02 27.92 37.79 20.18 19.07 -6.47 -13.53 -10.81 4.97 12.80 12.07
收入百分比 57.67 57.23 57.27 56.48 55.93 55.96 56.46 56.65 57.81 60.41 76.58 89.42 102.06 113.71 108.65 109.11 105.33 111.64 123.65 139.18
毛营业利润 23,488 22,805 22,119 23,250 24,097 24,875 26,587 26,501 26,359 25,810 15,404 8,213 -1,680 -11,974 -7,397 -6,707 -3,627 -7,846 -16,231 -26,771
改变 (%) -2.91 -3.01 5.12 3.64 3.23 6.88 -0.32 -0.53 -2.08 -40.32 -46.68 -120.46 612.53 -38.23 -9.33 -45.91 116.30 106.86 64.94
收入百分比 42.33 42.77 42.73 43.52 44.07 44.04 43.54 43.35 42.19 39.59 23.42 10.58 -2.06 -13.71 -8.65 -9.11 -5.33 -11.64 -23.65 -39.18
销售、一般及行政费用 21,760 22,047 21,548 24,405 25,270 26,096 27,274 27,345 27,661 26,689 18,554 19,305 18,962 42,977 52,444 50,609 49,443 32,096 37,743 52,802
改变 (%) 1.32 -2.27 13.26 3.55 3.27 4.51 0.26 1.15 -3.51 -30.48 4.05 -1.78 126.65 22.03 -3.50 -2.30 -35.09 17.59 39.90
收入百分比 39.22 41.35 41.63 45.68 46.21 46.20 44.66 44.73 44.27 40.94 28.21 24.87 23.20 49.19 61.32 68.73 72.68 47.64 55.00 77.28
研发 499 698 1,282 1,384 1,384 1,735 2,356 2,130 2,130 2,187 1,654 5,962 9,563 15,000 19,396 20,437 23,235 18,035 14,112 9,553
改变 (%) 39.92 83.79 7.96 0.00 25.36 35.78 -9.60 0.00 2.66 -24.38 260.50 60.40 56.86 29.31 5.37 13.69 -22.38 -21.76 -32.30
收入百分比 0.90 1.31 2.48 2.59 2.53 3.07 3.86 3.48 3.41 3.35 2.51 7.68 11.70 17.17 22.68 27.75 34.15 26.77 20.56 13.98
运营支出 55,484 54,401 53,620 57,009 58,281 60,456 65,019 64,948 66,756 69,395 71,521 95,580 113,043 158,054 165,430 152,027 144,954 125,955 137,303 158,046
改变 (%) -1.95 -1.44 6.32 2.23 3.73 7.55 -0.11 2.78 3.95 3.06 33.64 18.27 39.82 4.67 -8.10 -4.65 -13.11 9.01 15.11
收入百分比 99.99 102.03 103.59 106.70 106.58 107.04 106.48 106.25 106.84 106.45 108.73 123.13 138.29 180.91 193.44 206.46 213.07 186.94 200.09 231.32
营业收入 4 -1,081 -1,858 -3,581 -3,599 -3,975 -3,956 -3,818 -4,275 -4,204 -5,742 -17,953 -31,298 -70,690 -79,912 -78,392 -76,922 -58,577 -68,684 -89,721
改变 (%) -28,840.21 71.89 92.76 0.51 10.44 -0.48 -3.49 11.98 -1.66 36.58 212.67 74.33 125.86 13.05 -1.90 -1.88 -23.85 17.25 30.63
收入百分比 0.01 -2.03 -3.59 -6.70 -6.58 -7.04 -6.48 -6.25 -6.84 -6.45 -8.73 -23.13 -38.29 -80.91 -93.44 -106.46 -113.07 -86.94 -100.09 -131.32
利息花费 -62 -49 -40 -36 -36 -31 -25 -38 -38 -274 -828 -2,202 -3,656 -3,668 -4,304 -4,408 -4,350 -5,514 -6,094 -7,520
改变 (%) -20.80 -17.74 -11.42 -0.00 -12.89 -20.34 53.52 -0.00 620.59 201.78 165.91 66.04 0.33 17.33 2.42 -1.33 26.77 10.52 23.39
收入百分比 -0.11 -0.09 -0.08 -0.07 -0.07 -0.06 -0.04 -0.06 -0.06 -0.42 -1.26 -2.84 -4.47 -4.20 -5.03 -5.99 -6.39 -8.18 -8.88 -11.01
净利 9,179 11,253 9,406 7,325 5,472 8,103 8,984 10,384 12,172 12,639 10,916 -9,889 -19,222 -118,270 -125,383 -131,144 -141,774 -104,979 -141,984 -185,402
改变 (%) 22.59 -16.41 -22.13 -25.29 48.06 10.87 15.59 17.22 3.84 -13.63 -190.59 94.38 515.29 6.01 4.59 8.11 -25.95 35.25 30.58
收入百分比 16.54 21.10 18.17 13.71 10.01 14.35 14.71 16.99 19.48 19.39 16.60 -12.74 -23.51 -135.38 -146.62 -178.10 -208.39 -155.81 -206.91 -271.36

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista